Q2 2021 Heidelberg Pharma AG Earnings Call Transcript
Good afternoon, and welcome to the Heidelberg Pharma Half Yearly Financial Report 2021. The call will be hosted by Dr. Jan Schmidt-Brand, CEO and CFO of Heidelberg Pharma AG. My name is Molly, and I'll be your coordinator for today's conference. (Operator Instructions)
And now handing you over to Dr. Jan Schmidt-Brand, CEO and CFO, to begin today's conference. Please go ahead.
Thank you, Molly. Hello, ladies and gentlemen, and welcome to the Heidelberg Pharma conference call to discuss our results for the first half of 2021 and to provide a business update. My name is Jan Schmidt-Brand, and I am the CEO and CFO of the company. Joining me on the call today is my colleague, Professor Andreas Pahl, Chief Scientific Officer; and Katja Arnold, our Investor Relations consultant.
Please note that this presentation is available for download on the Heidelberg Pharma website. This conference call is being recorded, and the replay will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |